Affigen Inc. logo

Affigen Inc.

Affigen develops tumor-identifying therapies to treat cancer. By utilizing precision design, we can drive powerful immune responses against molecules unique to cancer, while minimizing the risk of damage to healthy tissues. Affigen focus on highly-automated process engineering and personal-scale biologics manufacturing in order to develop new therapies for previously “undruggable” targets. In effect, Affigen focus on cancer’s “Achille’s Heel”: the proteins which distinguish tumor cells from normal cells, which can target tumor cells for destruction with extreme sensitivity and precision. As a translational-stage company, Affigen develop our therapeutics with rapid clinical adoption in mind, and in close collaboration with an extensive expert network of world-class academic collaborators.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://www.affigen.com
Disease Focus
STOCK CODENon Listed
Address
20 S. Sarah St. 63108
Saint Louis
United States
Email
Contact Number
+1 314 254-5081